In addition, the genes that frequently showed recurrent nonsilent mutations in our study are consistent with the top breast cancer genes with driver mutations, PIK3CA, TP53, CDH1, APC, ERBB2, and FGFR1 [26]. This evidence concerns the gene ERBB2 and breast cancer.